Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $476M invested in Amphastar Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 51
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $429K
Holders
135
Holding in Top 10
–
Calls
–
Puts
$429K
Top Buyers
| 1 | +$4.27M | |
| 2 | +$3.95M | |
| 3 | +$3.04M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.94M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.23M |
Top Sellers
| 1 | -$8.45M | |
| 2 | -$4.52M | |
| 3 | -$2.72M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.17M |
| 5 |
Renaissance Technologies
New York
|
-$1.59M |